Belgian early-stage fund White Fund launches with €20 million to invest in medical devices | EU-Startups
Summary
White Fund currently has capital resources amounting to €20 million, with a goal of financing about ten of the most promising medtech projects in Belgium. It aims to have a positive impact on the healthcare sector, by means of instruments, software, implants and equipment that provide added value at different levels, such as diagnostic assistance, therapy solutions, facilitating medical practice and optimising the patient’s care path. “Medtech companies have their own life cycles and economic realities, including challenges, particularly of a regulatory nature, which must be considered at a very early stage, as soon as the project is structured,” said Tyrekidis and Fellin. “In addition to finance, we therefore wanted to develop a project that responds more effectively to identified weaknesses, which are generally shared by these companies and at this stage of development.” After discussing the idea with recognised entrepreneurs within the sector, they began to raise funds in October 2018. Belgium has extremely strong expertise in medtech, with high-ranking engineers and engineering schools, high quality care, internationally renowned specialist doctors and surgeons, centres of excellence for clinical studies linked to new technologies, a substantial network of SMEs and the long-standing presence of big players within the field.
Funding
Review available funding amount, funding date, investors, and linked company information related to Belgian early-stage fund White Fund launches with €20 million to invest in medical devices | EU-Startups in the interactive ISVWorld profile.